Skip to main content
Equibles

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in DYN — Dyne Therapeutics, Inc.

CIK 861177 NEW YORK, NY
Back to DYN Full portfolio

Position in DYN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$5,996,360
+$1,658,127 QoQ
Shares Held
269,985
+12.8% QoQ
Ownership
0.145%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 245 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 43% Shared 0% None 57%

Common Shares in DYN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. DYN ranks #55 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,086,683 $1,533,248,041
2 REGN
Regeneron Pharmaceuticals, Inc.
 716,560 $446,803,817
3 ALNY
Alnylam Pharmaceuticals, Inc.
 727,848 $219,104,078
4 INCY
Incyte Corp
 1,508,720 $171,028,494
5 RVMD
Revolution Medicines, Inc.
 912,335 $170,862,094
6 INSM
INSMED Inc
 1,335,071 $142,345,265
7 IONS
Ionis Pharmaceuticals Inc
 1,454,672 $115,340,938
8 MRNA
Moderna, Inc.
 1,521,849 $106,575,080

All Filings in DYN

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,996,360 269,985
2026-03-31 $4,338,233 239,285
2025-12-31 $4,195,438 214,491
2025-09-30 $2,902,287 229,430
2025-06-30 $2,795,489 293,644
2025-03-31 $1,650,490 157,791
2024-12-31 $3,377,629 143,363
2024-09-30 $4,825,274 134,334
2024-06-30 $4,501,236 127,550
2024-03-31 $888,066 31,281
2023-12-31 $337,672 25,389
2023-09-30 $109,508 12,222
2023-06-30 $137,497 12,222
2023-03-31 $140,796 12,222
2022-12-31 $141,652 12,222
2022-09-30 $155,219 12,222
2022-06-30 $83,965 12,222
2022-03-31 $117,819 12,222
2021-12-31 $145,319 12,222
2021-09-30 $198,484 12,222

Report a Problem

Category
Description
Email (optional, for follow-up)